Patents by Inventor Francisco Xavier Talamas

Francisco Xavier Talamas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20110300103
    Abstract: Method for treating an HCV infection and inhibiting HCV replication with a compound of formula I wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein
    Type: Application
    Filed: August 18, 2011
    Publication date: December 8, 2011
    Applicant: Roche Palo Alto LLC
    Inventors: Javier de Vicente Fidalgo, Jim Li, Ryan Craig Schoenfeld, Francisco Xavier Talamas, Joshua Paul Gergely Taygerly
  • Heterocyclic antiviral compounds
    Patent number: 8071797
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4, R5 and X are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Grant
    Filed: February 12, 2009
    Date of Patent: December 6, 2011
    Assignee: Roche Palo Alto LLC
    Inventors: Sharada Shenvi Labadie, Clara Jeou Jen Lin, Francisco Xavier Talamas, Robert James Weikert
  • Heterocyclic antiviral compounds
    Patent number: 8067442
    Abstract: Compounds having the formula I wherein R1, R2a, R2b, R2c, R3, Y and p are as defined herein and C2-C3 is a single or double bond are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: November 29, 2011
    Assignee: Roche Palo Alto LLC
    Inventors: Elbert Chin, Jim Li, Francisco Xavier Talamas, Beihan Wang
  • Heterocyclic antiviral compounds
    Patent number: 8063072
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4, and R5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Grant
    Filed: September 21, 2010
    Date of Patent: November 22, 2011
    Assignee: Roche Palo Alto LLC
    Inventors: Jim Li, Javier de Vincente Fidalgo, Ryan Craig Schoenfeld, Francisco Xavier Talamas
  • Quinoline inhibitors of HCV polymerase
    Patent number: 8026253
    Abstract: Compounds having the formula I wherein wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: September 27, 2011
    Assignee: Roche Palo Alto LLC
    Inventors: Javier de Vicente Fidalgo, Jim Li, Ryan Craig Schoenfeld, Francisco Xavier Talamas, Joshua Paul Gergely Taygerly
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20110123490
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4, R5, Ra, Rb, Rc, Rd and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: December 14, 2010
    Publication date: May 26, 2011
    Applicant: Roche Palo Alto LLC
    Inventors: RYAN CRAIG SCHOENFELD, Leanna Renee Staben, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20110070189
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4, and R5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: September 21, 2010
    Publication date: March 24, 2011
    Inventors: Jim Li, Javier de Vincente Fidalgo, Ryan Craig Schoenfield, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100330032
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4, and R5 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: June 24, 2010
    Publication date: December 30, 2010
    Inventors: Elbert Chin, Javier de Vicente Fidalgo, Jim Li, Alfred Sui-Ting Lui, Kristen Lynn McCaleb, Ryan Craig Schoenfeld, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100311760
    Abstract: Compounds having the formula I wherein wherein R1, R2, R3, R4, X1, X2, X3 and X4 and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: June 9, 2010
    Publication date: December 9, 2010
    Inventors: Javier de Vicente Fidalgo, Jim Li, Ryan Craig Schoenfeld, Francisco Xavier Talamas, Joshua Paul Gergely Taygerly
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100297073
    Abstract: Compounds having the formula I wherein wherein R1, R2, R3b, R4a, R4b, R4c and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: May 20, 2010
    Publication date: November 25, 2010
    Inventors: Elbert Chin, Jim Li, Albert Sui-Ting Lui, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100272677
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4, R5a, R5b, R5c and R6 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: April 23, 2010
    Publication date: October 28, 2010
    Inventors: Eun Kyung Lee, Ryan Craig Schoenfeld, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100226879
    Abstract: Compounds having the formula A-R wherein A is a hetereoaryl and R is Ia, Ib or Ic and wherein A, R, R1, R2a, R2b, R2c, R3a, R3b, R4, R5, R6, Ra, Rb, Rc, Rd, X, X1, X2 and n are as are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: March 5, 2010
    Publication date: September 9, 2010
    Inventors: Sarah C. Abbot, Alfred Sui-Ting Lui, Jim Li, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100158860
    Abstract: Compounds having the formula I wherein A, R1, R2, R3, R4a, R4b, R4c, R5, R6, R7a, R7b, Ar1, Rc, Rd, Re, Rf, X, n and p are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: December 14, 2009
    Publication date: June 24, 2010
    Inventors: Sandra Steiner, Jim Li, Ryan Craig Schoenfeld, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100111900
    Abstract: Compounds having the formula I wherein R1, R2, R3a, R3b, R3c, R4, R5 and p are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: October 30, 2009
    Publication date: May 6, 2010
    Inventors: Jim Li, Alfred Sui-Ting Lui, Kristen Lynn McCaleb, Francisco Xavier Talamas
  • HETEROCYCLIC ANTIVIRAL COMPOUNDS
    Publication number: 20100081658
    Abstract: Compounds having the formula I wherein R1, R2a, R2b, R2c, R3, Y and p are as defined herein and C2-C3 is a single or double bond are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: September 25, 2009
    Publication date: April 1, 2010
    Inventors: Elbert Chin, Jim Li, Francisco Xavier Talamas, Beihan Wang
  • PHOSPHODIESTERASE 4 INHIBITORS
    Publication number: 20100029689
    Abstract: PDE4 inhibition is achieved by novel compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formula I: wherein R1, R2, R3, and R4 are as defined herein.
    Type: Application
    Filed: July 2, 2009
    Publication date: February 4, 2010
    Applicants: MEMORY PHARMACEUTICALS CORPORATION, ROCHE PALO ALTO LLC
    Inventors: Allen T. HOPPER, Joan Marie CAROON, Elbert CHIN, Robert F. DUNN, Sharada Shenvi LABADIE, Jim LI, Richard Allen SCHUMACHER, Francisco Xavier TALAMAS
  • Heterocyclic antiviral compounds
    Publication number: 20100021423
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4a, R4b, R4c, R5, R6, R9 and n are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: July 22, 2009
    Publication date: January 28, 2010
    Inventors: Kenneth Albert Brameld, David Scott Carter, Elbert Chin, Javier de Vicente Fidalgo, Jim Li, Ryan Craig Schoenfeld, Eric Brian Sjogren, Francisco Xavier Talamas
  • Heterocyclic antiviral compounds
    Publication number: 20090208449
    Abstract: Compounds having the formula I wherein R1, R2, R3, R4, R5 and X are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
    Type: Application
    Filed: February 12, 2009
    Publication date: August 20, 2009
    Inventors: Sharada Shenvi Labadie, Clara Jeou Jen Lin, Francisco Xavier Talamas, Robert James Weikert
  • PHOSPHODIESTERASE 4 INHIBITORS
    Publication number: 20090118270
    Abstract: PDE4 inhibition is achieved by novel compounds, e.g., N-substituted diarylamine analogs. The compounds of the present invention are of Formulas I-III: wherein A, B, D, E, G, J, K, R1, R2, R3, R4, R11, R12, R13, R14, R21, R22, R23 and R24 are as defined herein.
    Type: Application
    Filed: December 5, 2008
    Publication date: May 7, 2009
    Inventors: Francisco Xavier Talamas, Joan Marie Caroon, Robert Dunn, Allen Hopper, Erik Kuester, Richard Schumacher, Ashok Tehim
  • Aminopyrimidine and aminopyridine anti-inflammation agents
    Patent number: 7157580
    Abstract: Aminopyrimidine and aminopyridine (I) compounds, compositions and methods useful in the treatment of inflammatory, metabolic or malignant conditions, are provided herein
    Type: Grant
    Filed: October 18, 2004
    Date of Patent: January 2, 2007
    Assignee: Roche Palo Alto LLC
    Inventors: Ronald Charles Hawley, Sharada Shenvi Labadie, Eric Brian Sjogren, Francisco Xavier Talamas